Displaying 601 - 610 of 657
JACKSONVILLE, Fla. (April 25, 2019) – The American Association of Clinical Endocrinologists (AACE) announced today two late-breaking research presentations that have been added to the agenda for AACE 2019, its 28th Annual Scientific & Clinical Congress taking place in Los Angeles this week.
On Friday, April 26, 2019, from 11am to 12pm PT, Raymond S. Douglas, MD, PhD, Clinician and Researcher at Cedars-Sinai Medical Center and board-certified oculoplastic surgeon with practices in Beverly Hills, Calif. and Shanghai, China, will present results for the largest clinical trial ever…
moreJACKSONVILLE, Fla. (May 3, 2019) – Members of the American Association of Endocrinologists (AACE), a professional community of physicians specializing in endocrinology, diabetes and metabolism, elected new officers for its Board of Directors at AACE 2019, its 28th Annual Scientific & Clinical Congress this past week in Los Angeles. AACE officers will serve on the Board of Directors for the 2019-2020 term.
Elected 2019-2020 AACE Board of Directors Officers:
- President:
Sandra L. Weber, MD, FACP
Chief of the Division of Endocrinology…
moreJACKSONVILLE, Fla. (April 28, 2019) – The American Association of Clinical Endocrinologists (AACE), a professional community of physicians specializing in endocrinology, diabetes, and metabolism, is pleased to announce the e-poster award winners from AACE 2019, its 28th Annual Scientific & Clinical Congress in Los Angeles this past week. Nearly 500 e-posters featuring innovative research, clinical trials, and case studies were presented during AACE 2019, and winners were selected by an esteemed panel of endocrinologists from around the world.
e-Poster Presentation Awards:… moreLewis E. Braverman, MD, MACE, 89, passed away peacefully on Monday, June 10, 2019. He leaves his wife Mimi Braverman; his sons, William Braverman and Daniel Braverman; and his five grandchildren.
Dr. Braverman was an undergraduate at Harvard College and graduated from medical school at Johns Hopkins University in 1955. He completed an Internal Medicine Residency at Boston City Hospital and an Endocrinology Fellowship in the Thorndike Memorial Laboratory.
Dr. Braverman had a passion for mentoring fellows, students and junior faculty, and is remembered as a superb mentor to generations…
moreAACE Member Felicia Cosman, MD, professor of medicine at Columbia University, New York, discussed the current state of osteoporosis treatment in an interview at AACE’s 28th Annual Scientific & Clinical Congress.
moreAACE Member Roy Taylor, MD
, discussed the pathogenesis of hepatic insulin resistance in people with type 2 diabetes in an interview at AACE’s 28th Annual Scientific & Clinical Congress.
moreAmong patients on hemodialysis, trabecular bone score was helpful in predicting fracture risk, researchers reported during an oral presentation of the findings at AACE’s 28th Annual Scientific & Clinical Congress.
moreThe investigational agent relacorilant significantly improved excess cortisol in patients with endogenous hypercortisolism, researchers reported at the AACE 28th Annual Scientific & Clinical Congress.
moreThe investigational agent teprotumumab was effective for reducing proptosis associated with thyroid eye disease, according to late-breaking phase III data presented by Raymond Douglas, MD, PhD, of Cedars Sinai Medical Center in Los Angeles, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.
more
